Company Filing History:
Years Active: 2013-2015
Title: Emmanouil D Karagiannis: Innovator in Angiogenesis Modulation
Introduction
Emmanouil D Karagiannis is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of angiogenesis, focusing on the modulation of blood vessel formation. With a total of 4 patents, his work has implications for various medical applications.
Latest Patents
Karagiannis's latest patents include innovative compositions that exhibit antiangiogenic activity. One of his notable patents describes compositions and methods useful for modulating blood vessel formation. This patent outlines a systematic computational methodology based on bioinformatics to identify novel peptide modulators of angiogenesis, which have been characterized both in vitro and in vivo. Another patent focuses on peptide modulators of angiogenesis, detailing similar methodologies for identifying effective modulators.
Career Highlights
Emmanouil D Karagiannis is affiliated with Johns Hopkins University, where he continues to advance research in his field. His work has garnered attention for its potential to impact therapeutic strategies in treating diseases related to abnormal blood vessel formation.
Collaborations
Karagiannis collaborates with Aleksander S Popel, a fellow researcher who shares his interest in the mechanisms of angiogenesis. Their partnership enhances the depth and breadth of research in this critical area of study.
Conclusion
Emmanouil D Karagiannis stands out as an influential inventor in the realm of angiogenesis modulation. His innovative patents and collaborative efforts contribute significantly to the advancement of medical science.